FusionPlex® Pan-Heme Panel

Hematologic malignancies (e.g. leukemias, lymphomas, myelomas, plasma cell neoplasms) frequently have chromosome rearrangements and gene fusions that are important in establishing a diagnosis, predicting prognosis, and guiding therapy choices. The FusionPlex® PanHeme Panel is based on next generation sequencing of RNA (cDNA) from bone marrow, leukemic blood, or lymph node tissue to detect somatic oncogenic gene fusions involving any of 72 genes associated with hematological malignancies, without prior knowledge of the fusion partners or the breakpoints of the translocations.

This test can also be ordered for a single gene or a subset of 2-10 genes, chosen by the ordering clinician based on clinical and pathological findings.

FusionPlex® Solid Tumor Panel

Solid tumors (e.g. sarcomas, lung cancers, thyroid cancers, head and neck cancers, renal cell carcinomas, mammary gland tumors, prostate cancers, brain tumors) frequently have chromosome rearrangements and gene fusions that are important in establishing a diagnosis, predicting prognosis, and guiding therapy choices. The FusionPlex® Solid Tumor Panel is based on next generation sequencing of RNA (cDNA) from solid tumor tissue to detect somatic oncogenic gene fusions involving any of over 100 genes associated with solid tumors, without prior knowledge of the fusion partners or the breakpoints of the translocations.

This test can also be ordered for a single gene or a subset of 2-10 genes, chosen by the ordering clinician based on clinical and pathological findings.

Droplet digital PCR (ddPCR) for deletions and duplications

This droplet digital PCR (ddPCR) test is most often used to test family members for deletions or duplications initially detected by chromosomal microarray analysis (CMA) or another test method.  It is a less expensive option than CMA.  ddPCR allows for detection of deletions and duplications that are too small to be seen using FISH or CMA.  ddPCR also targets only the deletion or duplication of interest.  This avoids the possibility of incidentally detecting a different copy number variant.